Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01492673
Title Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Memorial Sloan-Kettering Cancer Center
Indications
Therapies
Age Groups: adult | child
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Phoenix Children'S Hospital Phoenix Arizona 85016 United States Details
University of Colorado Health Sciences Center and The Children's Hospital Denver Colorado 80045 United States Details
MD Anderson Cancer Center Orlando at Arnold Palmer Hospital for Children Orlando Florida 32806 United States Details
Children's Mercy Hospital & Clinics Kansas City Missouri 64108 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Pennsylvania State University College of Medicine Hershey Pennsylvania 17110 United States Details
Alberta Children'S Hospital Calgary Alberta T2N 1N4 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field